Precigen, Inc. (PGEN)
Largest Insider Buys in Sector
PGEN Stock Price History Chart
PGEN Stock Performance
About Precigen, Inc.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Insider Activity of Precigen, Inc.
Over the last 12 months, insiders at Precigen, Inc. have bought $20.05M and sold $0 worth of Precigen, Inc. stock.
On average, over the past 5 years, insiders at Precigen, Inc. have bought $22.84M and sold $12.48M worth of stock each year.
Highest buying activity among insiders over the last 12 months: KIRK RANDAL J () — $180M. Perez Jeffrey Thomas (SVP, IP Affairs) — $50,000.
The last purchase of 23,529,411 shares for transaction amount of $20M was made by KIRK RANDAL J () on 2024‑08‑09.
List of Insider Buy and Sell Transactions, Precigen, Inc.
| 2024-08-09 | 23.53M 7.203% | $0.85 | $20M | -15.22% | ||||
| 2024-08-09 | SVP, IP Affairs | 58,823 0.018% | $0.85 | $50,000 | -15.22% | |||
| 2023-12-28 | Sale | director | 96,686 0.039% | $1.41 | $136,327 | -2.86% | ||
| 2023-12-28 | 96,686 0.039% | $1.41 | $136,327 | -2.86% | ||||
| 2023-09-22 | director | 25,000 0.0099% | $1.41 | $35,250 | -2.86% | |||
| 2023-08-25 | Sale | President and CEO | 76,969 0.0243% | $1.53 | $117,763 | -19.65% | ||
| 2023-08-24 | Sale | SVP, IP Affairs | 8,891 0.0034% | $1.64 | $14,581 | -9.15% | ||
| 2023-08-24 | Sale | Chief Legal Officer | 10,947 0.0042% | $1.64 | $17,953 | -9.15% | ||
| 2023-08-24 | Sale | Chief Financial Officer | 9,045 0.0035% | $1.64 | $14,834 | -9.15% | ||
| 2023-08-24 | Sale | Chief Operating Officer | 5,388 0.0021% | $1.64 | $8,836 | -9.15% | ||
| 2023-08-18 | Sale | President and CEO | 55,855 0.0225% | $1.66 | $92,719 | -13.66% | ||
| 2023-08-17 | Sale | SVP, IP Affairs | 8,741 0.0031% | $1.55 | $13,549 | -19.18% | ||
| 2023-08-17 | Sale | Chief Legal Officer | 10,762 0.0038% | $1.55 | $16,681 | -19.18% | ||
| 2023-08-17 | Sale | Chief Financial Officer | 8,893 0.0031% | $1.55 | $13,784 | -19.18% | ||
| 2023-08-17 | Sale | Chief Operating Officer | 5,298 0.0019% | $1.55 | $8,212 | -19.18% | ||
| 2023-08-16 | 119,411 0.0466% | $1.51 | $180,311 | -8.38% | ||||
| 2023-08-15 | 380,589 0.1477% | $1.52 | $577,301 | -8.82% | ||||
| 2023-08-14 | director | 400,000 0.1622% | $1.72 | $688,000 | -15.96% | |||
| 2023-08-14 | director | 570,345 0.2353% | $1.75 | $998,104 | -15.96% | |||
| 2023-08-11 | Sale | President and CEO | 41,436 0.0152% | $1.44 | $59,668 | -9.25% |
Insider Historical Profitability
| KIRK RANDAL J | 64547214 22.0396% | $1.12 | 70 | 12 | +7.38% | |
| Perez Jeffrey Thomas | SVP, IP Affairs | 743097 0.2537% | $1.12 | 3 | 20 | <0.0001% |
| Ares Trading S.A. | 10 percent owner | 20647152 7.05% | $1.12 | 1 | 67 | +52.74% |
| Sabzevari Helen | President and CEO | 1560004 0.5327% | $1.12 | 1 | 23 | <0.0001% |
| Frank Steven | director | 882358 0.3013% | $1.12 | 1 | 0 | |
| Hassan Fred | director | 878942 0.3001% | $1.12 | 2 | 0 | <0.0001% |
| Lehr Donald P. | Chief Legal Officer | 428916 0.1465% | $1.12 | 2 | 21 | +21.62% |
| MITCHELL DEAN J | director | 356836 0.1218% | $1.12 | 2 | 0 | <0.0001% |
| Sterling Rick L. | Chief Financial Officer | 340020 0.1161% | $1.12 | 0 | 13 | |
| KINDLER JEFFREY B | director | 238275 0.0814% | $1.12 | 2 | 2 | <0.0001% |
| Thomasian Harry Jr. | Chief Financial Officer | 161051 0.055% | $1.12 | 3 | 5 | <0.0001% |
| Reed Thomas D. | Chief Science Officer | 148888 0.0508% | $1.12 | 2 | 9 | +21.52% |
| Shah Rutul R | Chief Operating Officer | 133474 0.0456% | $1.12 | 1 | 4 | <0.0001% |
| Frost Gregory Ian | SVP--Health Sector | 100000 0.0341% | $1.12 | 3 | 0 | <0.0001% |
| LIFFMAN JOEL D | SVP, Finance | 85541 0.0292% | $1.12 | 1 | 2 | <0.0001% |
| SHAPIRO ROBERT B | director | 82966 0.0283% | $1.12 | 2 | 0 | <0.0001% |
| Bostick Thomas | Chief Operating Officer | 74280 0.0254% | $1.12 | 0 | 5 | |
| Krishnan Krish S | Chief Operating Officer | 42000 0.0143% | $1.12 | 1 | 2 | +59.01% |
| Krishnan Suma | SVP--Product Development | 42000 0.0143% | $1.12 | 1 | 2 | +59.01% |
| Walsh Robert F. III | SVP, Energy & Fine Chem. | 28816 0.0098% | $1.12 | 0 | 2 | |
| Kasser Thomas R. | SVP--Food Sector | 15000 0.0051% | $1.12 | 2 | 0 | +19.61% |
| Nimrodi Nir | Chief Business Officer | 5708 0.0019% | $1.12 | 2 | 1 | <0.0001% |
| Last Andrew J. | Chief Operating Officer | 4000 0.0014% | $1.12 | 2 | 0 | +0.56% |
| Huang Kelly | SVP-Consumer Sector | 3200 0.0011% | $1.12 | 1 | 0 | +59.01% |
| Gupta Vinita D | director | 3000 0.001% | $1.12 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Patient Capital Management Llc | $25.31M | 6.91 | 17.45M | +9.2% | +$2.13M | 1.23 | |
| BlackRock | $15.03M | 4.11 | 10.36M | -6.81% | -$1.1M | <0.0001 | |
| The Vanguard Group | $9.81M | 2.68 | 6.77M | +0.29% | +$28,818.75 | <0.0001 | |
| Geode Capital Management | $4.4M | 1.2 | 3.03M | +0.32% | +$13,904.17 | <0.0001 | |
| State Street | $4.1M | 1.12 | 2.83M | +5.25% | +$204,329.67 | <0.0001 | |
| Iridian Asset Management Llc Ct | $3.03M | 0.83 | 2.09M | +4.31% | +$125,192.99 | 0.6 | |
| D. E. Shaw & Co. | $2.59M | 0.71 | 1.78M | +76.82% | +$1.12M | <0.01 | |
| Millennium Management LLC | $1.99M | 0.54 | 1.37M | -51.84% | -$2.14M | <0.01 | |
| JPMorgan Chase | $1.88M | 0.51 | 1.29M | -3.62% | -$70,429.41 | <0.0001 | |
| Northern Trust | $1.57M | 0.43 | 1.08M | -0.01% | -$195.75 | <0.0001 | |
| Charles Schwab | $1.55M | 0.42 | 1.07M | +5.86% | +$85,708.04 | <0.0001 | |
| Morgan Stanley | $1.54M | 0.42 | 1.06M | -15.9% | -$291,422.34 | <0.0001 | |
| Renaissance Technologies | $1.53M | 0.42 | 1.05M | +20.35% | +$257,991.01 | <0.01 | |
| Opaleye Management Inc | $1.37M | 0.38 | 947,500 | -6.42% | -$94,250.00 | 0.3 | |
| SMH CAPITAL INC. | $1.02M | 0.28 | 705,000 | New | +$1.02M | 0.19 | |
| Nuveen | $775,725.00 | 0.21 | 534,983 | 0% | +$0 | <0.0001 | |
| Emfo Llc | $753,239.00 | 0.21 | 519,475 | 0% | +$0 | 0.7 | |
| ClariVest Asset Management LLC | $693,680.00 | 0.19 | 478,400 | +0.19% | +$1,297.75 | 0.07 | |
| BNY Mellon | $583,607.00 | 0.16 | 402,487 | -9.84% | -$63,675.39 | <0.0001 | |
| MSD Partners LP | $514,750.00 | 0.14 | 355,000 | 0% | +$0 | 0.04 | |
| Citadel Advisors LLC | $460,021.00 | 0.13 | 317,256 | -40.31% | -$310,682.66 | <0.0001 | |
| Fore Capital Llc | $444,847.00 | 0.12 | 306,791 | -14.01% | -$72,500.01 | 2.77 | |
| Advisor Group Holdings Inc | $433,030.00 | 0.12 | 298,642 | -4.3% | -$19,482.16 | <0.01 | |
| Goldman Sachs | $412,433.00 | 0.11 | 284,436 | -0.22% | -$919.30 | <0.0001 | |
| CETERA INVESTMENT ADVISERS LLC | $377,742.00 | 0.1 | 260,512 | +3.55% | +$12,958.64 | <0.01 | |
| Fidelity Investments | $370,671.00 | 0.1 | 255,635 | -0.11% | -$407.45 | <0.0001 | |
| Cetera Advisors LLC | $366,553.00 | 0.1 | 252,795 | New | +$366,553.00 | <0.01 | |
| Gsa Capital Partners Llp | $324,000.00 | 0.09 | 223,288 | -60.93% | -$505,216.13 | 0.03 | |
| RhumbLine Advisers | $294,539.00 | 0.08 | 203,137 | -2.34% | -$7,051.12 | <0.0001 | |
| Exchange Traded Concepts, LLC | $288,920.00 | 0.08 | 199,255 | +111.77% | +$152,487.93 | 0.01 | |
| AllianceBernstein | $267,917.00 | 0.07 | 184,770 | 0% | +$0 | <0.0001 | |
| UBS | $246,377.00 | 0.07 | 169,915 | -20.81% | -$64,729.52 | <0.0001 | |
| Cibc Private Wealth Group Llc | $237,625.00 | 0.07 | 166,171 | 0% | +$0 | <0.0001 | |
| T. Rowe Price | $240,000.00 | 0.07 | 165,152 | +3.32% | +$7,707.81 | <0.0001 | |
| Panagora | $226,509.00 | 0.06 | 156,213 | -48.51% | -$213,399.54 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $222,574.00 | 0.06 | 153,499 | +269.89% | +$162,400.33 | <0.0001 | |
| Bank of America | $191,676.00 | 0.05 | 132,190 | -63.2% | -$329,179.86 | <0.0001 | |
| Barclays | $164,000.00 | 0.05 | 113,296 | -45.15% | -$134,974.02 | <0.0001 | |
| Summit Trail Advisors | $151,567.00 | 0.04 | 104,529 | 0% | +$0 | <0.01 | |
| Two Sigma Advisers LP | $145,000.00 | 0.04 | 100,000 | -0.6% | -$870.00 | <0.0001 | |
| Wells Fargo | $140,984.00 | 0.04 | 97,231 | -1.38% | -$1,969.09 | <0.0001 | |
| Jane Street Capital | $133,317.00 | 0.04 | 91,943 | -55.41% | -$165,667.86 | <0.0001 | |
| Lexaurum Advisors Llc | $129,291.00 | 0.04 | 89,166 | -8.8% | -$12,470.03 | 0.04 | |
| Cary Street Partner Investment Advisory Llc | $124,516.00 | 0.03 | 85,873 | 0% | +$0 | 0.01 | |
| Cambridge Investment Research Advisors Inc | $113,000.00 | 0.03 | 78,184 | +12.68% | +$12,718.72 | <0.0001 | |
| Tudor Investment Corp Et Al | $103,623.00 | 0.03 | 71,464 | 0% | +$0 | <0.01 | |
| Virtus ETF Advisers LLC | $99,708.00 | 0.03 | 68,764 | -6.41% | -$6,833.86 | 0.03 | |
| Hightower Advisors | $97,000.00 | 0.03 | 69,100 | -19.51% | -$23,517.24 | <0.0001 | |
| MetLife Investment Management | $98,120.00 | 0.03 | 67,669 | +2.27% | +$2,182.25 | <0.01 | |
| American Financial Group | $96,000.00 | 0.03 | 66,114 | 0% | +$0 | 0.04 |